Funding for this research was provided by:
Canadian Cancer Society Research Institute (702601)
Received: 23 November 2018
Accepted: 9 September 2019
First Online: 28 October 2019
Ethics approval and consent to participate
: The Research Ethics Board at St. Michael’s Hospital in Toronto, Ontario approved this study (REB# 15–220). All participants who attended the stakeholder meeting and contributed to the development of the BEFORE DA and/or alpha testing provided written consent prior to participation in the study.
: Not applicable.
: The authors declare that they have no competing interests.